The Government has heeded the calls from Medicines Australia, patient groups, health bodies, and industry by extending the finalisation of the National Medicines Policy (NMP) Review until after the Federal election.
Read more arrow_forward
Rare Cancers Australia (RCA) welcomes the Government’s $61.2 million funding commitment announced today for Omico’s Project, PrOSPeCT.
Read more arrow_forwardMedicines Australia and Rare Cancers Australia yesterday provided pharmaceutical industry stakeholders a…
Read more arrow_forwardRare Cancers Australia welcomes the appointment of Bruce Goodwin, recently retired Managing Director of Janssen Pharmaceuticals in ANZ, to the Board of RCA.
Read more arrow_forwardThe Hon. Greg Hunt MP, Minister for Health, announced on Tuesday the novel life-saving cancer treatment CAR-T therapy will be used for adult patients and manufactured in Australia.
Read more arrow_forward